Literature DB >> 18474877

Individualized treatment selection in patients with head and neck cancer: do molecular markers meet the challenge?

Bhuvanesh Singh, David G Pfister.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18474877     DOI： 10.1200/JCO.2007.14.7298

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Current potential and limitations of molecular diagnostic methods in head and neck cancer.

Authors:  Magdy E Mahfouz; Juan P Rodrigo; Robert P Takes; Mohamed N Elsheikh; Alessandra Rinaldo; Ruud H Brakenhoff; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06       Impact factor: 2.503

2.  Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.

Authors:  Zachary S Morris; Jamey P Weichert; Jarob Saker; Eric A Armstrong; Abigail Besemer; Bryan Bednarz; Randall J Kimple; Paul M Harari
Journal:  Radiother Oncol       Date:  2015-06-26       Impact factor: 6.280

3.  Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.

Authors:  William A Michaud; Anthony C Nichols; Edmund A Mroz; William C Faquin; John R Clark; Shahnaz Begum; William H Westra; Hiroshi Wada; Paul M Busse; Leif W Ellisen; James W Rocco
Journal:  Clin Cancer Res       Date:  2009-02-24       Impact factor: 12.531

Review 4.  Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy.

Authors:  Ulrich Keller; Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Journal:  J Cell Mol Med       Date:  2010-02-16       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.